Correction to: Antidepressant-Like Action of Single Facial Injection of Botulinum Neurotoxin A is Associated with Augmented 5-HT Levels and BDNF/ERK/CREB Pathways in Mouse Brain

Correction to: Neurosci. Bull. 10.1007/s12264-019-00367-8

In the original publication, Figure 4G was incorrectly published. The correct version of Figure 4G is presented in this correction. This correction does not affect the conclusions of the paper.

Fig. 4.

BoNT/A treatment attenuates depression-like behaviors in SRS mice. A The experimental procedure. B Body weight. C, D Immobility time in the FST (C) and TST (D) was increased in SRS-treated mice. *P < 0.05, **P < 0.01, ***P < 0.001 vs. controls. Student’s t-test; n = 10–22/group. E There was no significant difference in sucrose preference between SRS and control mice. Student’s t-test; n = 7–10/group. F, G Immobility time in the FST (F) and TST (G) at different time points after BoNT/A injection in SRS mice. H Body weight at different time points after BoNT/A injection in SRS mice. *P < 0.05, **P < 0.01, ***P < 0.001 vs. controls (two-way ANOVA with post hoc Bonferroni test). ^#P < 0.05, ^##P < 0.01 vs. SRS mice (two-way ANOVA with post hoc Bonferroni test). The data are presented as mean ± SEM, n = 7–10/group. Con, control; FLX, fluoxetine; SRS, space restriction stressed.